Compare ARK Genomic Revolution ETF (ARKG) vs Lumen Technologies Inc (LUMN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Lumen Technologies Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Lumen Technologies Inc trades at $6.72 (market cap $6.93B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lumen Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LUMN | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $11.83 |
52-Week Low | $23.09 | $3.70 |
Market Cap | — | $6.93B |
Enterprise Value | — | $18.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
LUMN trades at $6.73, down 0.3% on the day, with a bearish technical signal but oversold RSI readings. The company reported a net loss of -$1.74B for 2025, though revenue remains substantial at $12.40B. Recent news highlights the acquisition of Alkira to bolster AI-era networking capabilities and cost-saving initiatives targeting $1B annually by 2027. Debt levels are high at $17.49B long-term, but leverage is trending downward.
The outlook is mixed: positive catalysts include strategic acquisitions and cost reductions, but persistent losses and high debt pose significant risks. Analyst consensus is cautious with a Hold rating predominating, though the $8.25 price target suggests modest upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →
